Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 5/20 | 0.66 |
| ▸ | DRD2 | P14416 | 3/20 | 0.66 |
| ▸ | HTR1A | P08908 | 2/20 | 0.66 |
| ▸ | HTR1D | P28221 | 1/20 | 0.66 |
| ▸ | HTR2A | P28223 | 1/20 | 0.66 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7399648 | 0.99 | DRD4 (0.64) | DRD4DRD2HTR1AHTR1DHTR2A | |
| SCHEMBL7397854 | 0.93 | DRD4 (0.68) | DRD4DRD2HTR1AHTR1DHTR2A | |
| Hydrochloric Acid SCHEMBL8185604 | 0.92 | DRD4 (0.67) | DRD4DRD2HTR1AHTR1DHTR2A | |
| SCHEMBL7403278 | 0.85 | ALDH1A1 (0.59) | DRD4DRD2HTR1AHTR2ASIGMAR1 | |
| Hydrochloric Acid SCHEMBL7401194 | 0.84 | ALDH1A1 (0.58) | DRD4DRD2HTR1AHTR2ASIGMAR1 | |
| SCHEMBL7406795 | 0.83 | SIGMAR1 (0.47) | DRD4DRD2HTR1AHTR1DHTR2A | |
| Hydrochloric Acid SCHEMBL7401132 | 0.82 | SIGMAR1 (0.47) | DRD4DRD2HTR1AHTR1DHTR2A | |
| SCHEMBL7407464 | 0.82 | DRD2 (0.88) | DRD4DRD2HTR1AHTR1DHTR2A | |
| SCHEMBL7402337 | 0.81 | DRD2 (0.48) | DRD4DRD2HTR1AHTR1DHTR2A | |
| Hydrochloric Acid SCHEMBL7398494 | 0.81 | DRD4 (0.56) | DRD4DRD2HTR1AHTR1DHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0737189-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1996-10-16 | — | — | EP | claimed |
| WO-1995018118-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | THE UPJOHN COMPANY (US) | 1995-07-06 | — | — | WO | claimed |
| US-6133446-A | Heterocyclic compounds for the treatment of CNS and cardiovascular disorders | PHARMACIA & UPJOHN COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0737189-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018118-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | THE UPJOHN COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |